Overview

Melatonin Use in the Intensive Care Elderly Population

Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The investigators are studying the use of Melatonin in non-ventilated patients over the age of 65. Primary endpoint will be assesments of delirium, with secondary endpoints to include length of stay, use of anti-psychotic medications, and mortality
Phase:
Phase 4
Details
Lead Sponsor:
MICE Trial Group
Treatments:
Melatonin